Our data revealed a significant decrease in the ratio of CD4+/CD8+ also the percentage of CD4+ cells in peripheral blood of patients with osteosarcoma compared to patients with GCT and healthy controls. The gene discussed is CD8A; the disease is granular cell tumor.